Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Alcohol-Mediated Renal Denervation Appears Safe for BP Reduction

Key clinical point: Delivered by injection, alcohol-based renal denervation was associated with efficacy and safety in pilot study.

Major finding: At six months, mean 24-hour ambulatory systolic blood pressure was reduced 11 mmHg.

Data Source: Open label study.

Disclosures: Dr. Sievert did not include Ablative Solutions, the developer of the Peregrine System Kit, on a list of pharmaceutical and device manufacturers with which he has financial relationships.


2019 Cardiovascular Research Technologies.

This Week's Must Reads

CVD Event Rates Among Adults with PCSK9 Inhibition, Cardiovasc Drugs Ther; ePub 2019 Feb 11; Colantonio, et al

Statin Adherence & Mortality in Patients with ASCVD, JAMA Cardiol; ePub 2019 Feb 13; Rodriguez, et al

Physician Monitoring & LDL-C Follow-Up Testing , Prev Med; 2019 Apr; Dansinger, Williams, et al

CVD Prevalence in HeFH After Statin Treatment, Atherosclerosis; ePub 2019 Feb 12; Perez-Calahorra, et al

Must Reads in Hypertension

Antihypertensive Medications and Thrombolysis Therapy, J Clin Hypertens; ePub 2019 Jan 23; Fleming, et al

Admission BP & Outcomes in Patients with TIA, Am J Cardiol; ePub 2019 Jan 11; Bangalore, et al

Hypertension and ECG-LVH and CV Mortality, Am J Cardiol; ePub 2018 Oct 18; Cao, et al

Obtaining a Reliable Estimate of Home Blood Pressure, J Am Heart Assoc; ePub 2018 Oct 5; Bello, et al